Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma × Standard of Care × Clear all

Phase

Phase NA 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 7 Lung Neoplasms 5 Head and Neck Neoplasms 5 Neoplasms 4 Leukemia, Myeloid, Acute 4 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Recurrence 2 Pulmonary Disease, Chronic Obstructive 2 Neoplasm Metastasis 2 Leukemia 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Xerostomia 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Teratoma 1 Stroke 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Diseases 1

Interventions

Cyclophosphamide 54 Vincristine 52 Doxorubicin 50 Rituximab 43 Prednisone 40 Etoposide 33 Radiotherapy 32 Cytarabine 24 Filgrastim 20 Methotrexate 18 Bleomycin 18 Dexamethasone 16 Carmustine 13 Vinblastine 12 VAP-cyclo protocol 11 Prednisolone 11 Peripheral Blood Stem Cell Transplantation 11 Melphalan 11 Mitoxantrone 9 Mercaptopurine 9 Dacarbazine 9 Leucovorin 8 Procarbazine 7 Lenalidomide 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Gemcitabine 7 ibrutinib 6 Epoetin Alfa 6 Daunorubicin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡